Clinical Trial: Real World Study on the Use of Cemiplimab in Adult Patients in UK
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Cutaneous Squamous Cell Carcinoma
Study Type: Observational
Official Title: Real-world Evidence Study on the Early Use of Cemiplimab in the UK: REACT-CEMI (Real World Evidence of Advanced CSCC Treatment - With CEMIplimab)
Brief Summary:
The primary objective is to describe the real-world clinical effectiveness of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma (laCSCC) or metastatic cutaneous squamous cell carcinoma (mCSCC) treated in routine clinical practice.
Read more